Amakhasimende abalulekile athandekayo:
Njengoba ubhubhane lwe-SARS-CoV-2 luqhubeka, uguquko olusha nokuhlukahluka kwaleli gciwane kuyaqhubeka nokuvela, okungelona i-atypical. Njengamanje, kugxilwe ekwehlukeni okuvela eNgilandi naseNingizimu Afrika okungenzeka kunyuke ukutheleleka, futhi umbuzo uwukuthiukuhlolwa okusheshayo kwe-antigenfuthi ingathola lokhu kuguquka.
Ngokophenyo lwethu, izinguquko eziningana zesayithi zenzekile ze-spike protein ezindaweni ezingu-N501Y, E484K, K417N ze-SA mutant strain 501Y.V2, kanye ne-N501Y, P681H, 69-70 ye-UK mutant strain b.1.1.7 (Kusuka I-Guangdong Provincial Center for Disease Control and Prevention). Njengoba indawo yokuqashelwa kwezinto ezingavuthiwe ezisetshenziswa ekuhlolweni kwethu kwe-antigen kuyiphrotheni ye-nucleocapsid ehlukile kumasayithi okuguqula, Le phrotheni itholakala ebusweni begciwane futhi iyadingeka ukuze igciwane lingene kuseli elibambayo.
Kodwa-ke, i-Testsealabs COVID-19 Antigen Rapid Test ihlola elinye iphrotheni yaleli gciwane, okuthiwa yi-nucleocapsid protein, etholakala ngaphakathi kwaleli gciwane futhi ayishintshwa wuguquko. Ngakho-ke, ngokwesimo samanje sesayensi, lokhu okuhlukile kungatholwa nayi-Testsealabs COVID-19 Antigen Rapid Test.
Okwamanje, sizokuthinta ngokushesha noma yiziphi izibuyekezo eziphathelene ne-SARS-CoV-2I-Antigen Rapid Test Kit. Ukwengeza, sizoqhubeka nemizamo yethu yokuhambisana nokuphezuluamazinga okuphatha ikhwalithi kanye nokugcina uhlelo lokuphatha lwekhwalithi ephezulu olungaguquki ukuze kuqinisekiswe ukwaneliseka kwamakhasimende nokuphepha komkhiqizo. Uma unemibuzo, sicela uthinte omele ukuthengisa.
I-Hangzhou Testsea Biotechnology Co., Ltd
Isikhathi sokuthumela: Jan-21-2021